Recent times have seen the rise of various infectious diseases and since the beginning of 2020, millions have been affected by a viral infection. 1 Diabetes has been identified as a primary risk factor for the development of pneumonia due to virus infection and occurs in about 20% of patients. 2,3 Glycemic management and benefit/risk assessment of overall treatment during these times is the key challenge. Improved glycemic control correlates to a better outcome in patients with infectious disease and pre-existing diabetes. 4 To understand the I mportance of glucovigilance during these times , Roche Diabetes Care India Pvt.
Ltd. and Docplexus have organized an interactive webinar on 27 th June 2020 from 5:00 PM - 5:45 PM . In this webinar session, Dr. Ganapathi Bantwal and Dr. Samit Ghosal shall discuss "Importance of Glucovigilance During These Times." We invite you to share…
